Stock ANIK ANIKA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Anika Therapeutics, Inc.

Equities

ANIK

US0352551081

Market Closed - Nasdaq
Other stock markets
 21:00:00 10/05/2024 BST 		5-day change 1st Jan Change
25.63 USD +1.46% Intraday chart for Anika Therapeutics, Inc. -7.10% +13.11%
05-08 Transcript : Anika Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024
05-08 Earnings Flash (ANIK) ANIKA THERAPEUTICS Reports Q1 EPS $0.09 MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Earnings Flash (ANIK) ANIKA THERAPEUTICS Reports Q1 EPS $0.09
MT
Earnings Flash (ANIK) ANIKA THERAPEUTICS Reports Q1 Revenue $40.5M, vs. Street Est of $39.1M
MT
Anika Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Anika Therapeutics Swings to Q4 Earnings As Revenue Rises; to Cut 9% Workforce
MT
Anika Therapeutics Guides For FY 2024 Revenue of $168-$173 Million, vs CIQ Analyst Consensus of $179 Million
MT
Earnings Flash (ANIK) ANIKA THERAPEUTICS Reports Q4 EPS $0.05, vs. Street Est of $-0.23
MT
Earnings Flash (ANIK) ANIKA THERAPEUTICS Posts Q4 Revenue $43M, vs. Street Est of $41.4M
MT
Anika Therapeutics, Inc. Provides Earnings Guidance for the Fiscal Year 2024
CI
Anika Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Anika Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Activist investor Caligan discloses 9.7% stake in Anika, nominates two director candidates
RE
Anika Therapeutics, Inc. Announces First Surgeries Performed Using the Integrity Implant System
CI
Tranche Update on Anika Therapeutics, Inc.'s Equity Buyback Plan announced on April 13, 2023.
CI
Earnings Flash (ANIK) ANIKA THERAPEUTICS Posts Q3 EPS $0.00, vs. Street Est of $-0.35
MT
Earnings Flash (ANIK) ANIKA THERAPEUTICS Reports Q3 Revenue $41.5M, vs. Street Est of $38.3M
MT
Anika Therapeutics, Inc. Revises Revenue Guidance for the Fiscal Year 2023
CI
Anika Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Anika Therapeutics, Inc. Announces the Full Market Release of the Revomotion Reverse Shoulder Arthroplasty System
CI
Anika Therapeutics, Inc. Receives 510(k) Clearance for Integrity? Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs
CI
Tranche Update on Anika Therapeutics, Inc.'s Equity Buyback Plan announced on April 13, 2023.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ANIK Stock
  4. News Anika Therapeutics, Inc.
  5. Highlights